Related Experiment Video
Updated: Aug 8, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Homocysteine and coronary heart disease: a review of the current evidence
1University of Texas Medical School and Memorial Hermann Hospital, Houston, TX, USA. vpasceri@hotmail.com
Insights
High homocysteine levels (hyperhomocysteinemia) may link to coronary heart disease. Ongoing trials investigate if lowering homocysteine reduces cardiac events and mortality.
Area of Science:
- Cardiovascular Science
- Metabolic Disorders
Background:
- Premature atherosclerosis in homocystinuria patients suggests a link between hyperhomocysteinemia and coronary heart disease.
- Severe homocysteinemia exhibits endothelial toxicity and may disrupt hemostatic balance.
Purpose of the Study:
- To investigate the association between hyperhomocysteinemia and coronary heart disease.
- To evaluate the impact of homocysteine reduction on cardiac events and mortality.
Main Methods:
- Review of experimental studies on homocysteinemia's effects.
- Analysis of case-control studies on mild hyperhomocysteinemia and heart disease.
- Monitoring results from ongoing randomized trials.
Main Results:
- Experimental data indicate endothelial toxicity and hemostatic alterations with severe homocysteinemia.
- Case-control studies suggest an association between mild hyperhomocysteinemia and coronary heart disease.
- Prospective studies have yielded inconsistent findings regarding this association.
Conclusions:
- The relationship between hyperhomocysteinemia and coronary heart disease requires further clarification.
- Randomized trials are crucial to determine if homocysteine level reduction impacts cardiac events and mortality.
Abstract:
The high frequency of premature atherosclerosis in patients with homocystinuria suggested the hypothesis of an association between hyperhomocysteinemia and coronary heart disease. Experimental studies have shown that severe homocysteinemia has toxic effects on the endothelium and may alter haemostatic balance. Although case controls studies have suggested a significant association between mild hyperhomocyst(e)inemia and coronary heart disease, prospective studies have not completely confirmed these findings. Results from the ongoing randomized trials will help determine whether reduction of homocysteine levels will be associated with a reduction of cardiac events and possibly mortality in patients.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
05:57The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations